
The Antifragile Pharma Supply Chain
Get Your Complimentary White Paper
You are one step away from accessing the C-suite roadmap to engineering antifragility into your supply chain.
This paper, Beyond Resilience: Engineering the Anti-Fragile Pharma Supply Chain of 2030, from Decision Lab CEO David Buxton provides a strategic playbook for moving beyond mere “resilience” to build a system that gains strength and capability from market volatility.
Discover how to:
- De-risk multi-billion dollar CAPEX decisions with strategic Digital Twins.
- Master escalating factory complexity using AI agents that learn and adapt.
- Create a predictive, “self-healing” value chain that thrives on disruption.
Complete the form to download your copy now and begin building the competitive frontier for 2030.